Publications by Dr Lisa Russell - ePrints

Browsing publications by Dr Lisa Russell.

Newcastle Authors	Title	Year
Brigid Davidson Dr Juliana Arcila Galvis Dr Marco Trevisan-Herraz Dr Aneta Mikulasova Dr Lisa Russell et al.	Evolutionarily conserved enhancer-associated features within the MYEOV locus suggest a regulatory role for this non-coding DNA region in cancer	2024
Dr Lisa Russell	Genetic alterations in lymphoblastic leukaemia / lymphoma – a practical guide to WHO HAEM5	2024
Dan Kent Dr Letizia Marchetti Dr Aneta Mikulasova Dr Lisa Russell Dr Daniel Rico Rodriguez et al.	Broad H3K4me3 domains: Maintaining cellular identity and their implication in super-enhancer hijacking	2023
Claire Schwab Dr Ruth Cranston Dr Sarra Ryan Ellie Butler Emily Winterman et al.	Integrative genomic analysis of childhood acute lymphoblastic leukaemia lacking a genetic biomarker in the UKALL2003 clinical trial	2023
Dr Simon Bomken Dr Amir Enshaei Dr Ed Schwalbe Dr Aneta Mikulasova Dr Masood Zaka et al.	Molecular characterisation and clinical outcome of B-cell precursor acute lymphoblastic leukaemia with IG-MYC rearrangement	2023
Sarra Ryan Claire Schwab Dr Richard Yim Dr Ruth Cranston Dr Lisa Russell et al.	Whole genome sequencing provides comprehensive genetic testing in childhood B-cell acute lymphoblastic leukaemia	2023
Dr Aneta Mikulasova Dr Lisa Russell Dr Daniel Rico Rodriguez	Dynamics of broad H3K4me3 domains uncover an epigenetic switch between cell identity and cancer-related genes	2022
Dr Ricky Tirtakusuma Dr Katarzyna Szoltysek Professor Vasily Grinev Dr Sirintra Nakjang Dr Daniel Williamson et al.	Epigenetic regulator genes direct lineage switching in MLL/AF4 leukemia	2022
Dr Aneta Mikulasova Dan Kent Dr Marco Trevisan-Herraz Nefeli Karataraki Kent Fung et al.	Epigenomic translocation of H₃K₄me₃ broad domains over oncogenes following hijacking of super-enhancers	2022
Dr Deepali Pal Dr Helen Blair Sean Hockney Dr Melanie Beckett Mankaran Singh et al.	hiPSC-derived bone marrow milieu identifies a clinically actionable driver of niche-mediated treatment resistance in leukemia	2022
Dr Helen Blair Professor Christine Harrison FRCPath FMedSci Dr Lisa Russell	Single cell analysis identifies CRLF2 rearrangements as both early and late events in Down syndrome and non-Down syndrome acute lymphoblastic leukaemia	2019
Dr Paul Sinclair Dr Helen Blair Dr Sarra Ryan Dr Lars Buechler Joanna Cheng et al.	Dynamic clonal progression in xenografts of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21	2018
Dr Lisa Russell Lisa Jones Dr Amir Enshaei Dr Stefano Tonin Sarra Ryan et al.	Characterisation of the genomic landscape of CRLF2-rearranged acute lymphoblastic leukemia	2016
Dr Alex Elder Dr Klaus Rehe Dr Simon Bomken Dr Paul Sinclair Katie Dormon et al.	The ability to cross the blood-cerebrospinal fluid barrier is a generic property of acute lymphoblastic leukemia blasts.	2016
Claire Schwab Dr Amir Enshaei Dr Lisa Russell Professor Anthony Moorman	The Frequency and Outcome of Ph-like ALL Associated Abnormalities in Childhood Acute Lymphoblastic Leukaemia Treated on MRC UKALL2003	2016
Dr Mark Wade Dr Nicola Sunter Dr Sarah Fordham Anna Long Dino Mašić et al.	c-MYC is a radiosensitive locus in human breast cells	2015
Dr Klaus Rehe Dr Simon Bomken Dr Paul Sinclair Dr Lisa Russell Professor Olaf Heidenreich et al.	Childhood pre-B acute lymphoblastic leukaemia cells capable of central nervous system engraftment are common, heterogeneous and transit the blood-cerebrospinal fluid barrier	2015
Dr Lisa Russell Lisa Jones Dr Amir Enshaei Dr Stefano Tonin Dr Sarra Ryan et al.	Clincial and Genetic Landscapes Differ Between IGH-CRLF2 and P2RY8-CRLF2 Acute Lymphoblastic Leukaemia	2015
Dr Lisa Russell Lisa Jones Dr Amir Enshaei Jamie Rutherford Dr Stefano Tonin et al.	Clincial and Genetic Landscapes Differ Between IGH-CRLF2 and P2RY8-CRLF2 Acute Lymphoblastic Leukaemia	2015
Dr Dino Masic Dr Amir Enshaei Lisa Jones Professor Christine Harrison FRCPath FMedSci Dr Lisa Russell et al.	Genetic Characterisation of Immunoglobulin Heavy Chain Locus CCAAT Enhancer-Binding Protein Translocated Acute Lymphoblastic Leukaemia	2015
Dino Mašić Dr Amir Enshaei Lisa Jones Professor Christine Harrison FRCPath FMedSci Dr Lisa Russell et al.	Genetic Characterisation of Immunoglobulin Heavy Chain Locus CCAAT Enhancer-Binding Protein Translocated Acute Lymphoblastic Leukaemia	2015
Dr Jeyanthy Eswaran Dr Paul Sinclair Professor Olaf Heidenreich Professor Julie Irving Dr Lisa Russell et al.	The pre-B-cell receptor checkpoint in acute lymphoblastic leukaemia	2015
Dr Lisa Russell Dr Amir Enshaei Lisa Jones Dr Amy Erhorn Dr Dino Masic et al.	IGH@ Translocations Are Prevalent in Teenagers and Young Adults With Acute Lymphoblastic Leukemia and Are Associated With a Poor Outcome	2014
Lisa Jones Professor Christine Harrison FRCPath FMedSci Dr Lisa Russell	IGH@ Translocations Co-exist With Other Primary Rearrangements in B-cell Precursor Acute Lymphoblastic Leukemia	2014
Dr Lisa Russell	Chromosomal translocations involving the IGH@ locus in B-cell precursor acute lymphoblastic leukemia: 29 new cases and a review of the literature.	2013
Claire Schwab Dr Lucy Chilton Heather Morrison Lisa Jones Dr Halima Al-shehhi et al.	Genes commonly deleted in childhood B-cell precursor acute lymphoblastic leukemia: association with cytogenetics and clinical features	2013
Dr Lisa Russell Professor Christine Harrison FRCPath FMedSci	Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL	2013
Dr Lisa Russell Hannah Ensor Professor Anthony Moorman	Unravelling the prognostic effect of IKZF1 deletions and IGH@-CRLF2 in adult acute lymphoblastic leukaemia	2013
Professor Anthony Moorman Claire Schwab Hannah Ensor Dr Lisa Russell Heather Morrison et al.	IGH@ Translocations, CRLF2 Deregulation and Microdeletions in Adolescents and Adults with Acute Lymphoblastic Leukemia	2012
Claire Schwab Dr Lucy Chilton Dr Amir Enshaei Heather Morrison Lisa Jones et al.	Clinical Relevance of Genes Commonly Deleted in Childhood B-Cell Precursor ALL (BCP-ALL)	2012
Claire Schwab Dr Lucy Chilton Heather Morrison Lisa Jones Dr Halima Al-shehhi et al.	Genes Commonly Deleted in Childhood B-Cell Precursor ALL (BCP-ALL) Are Associated with Major Cytogenetic Subgroups	2012
Dr Lisa Russell Lisa Jones Dr Amy Erhorn Dr Amir Enshaei Dino Mašić et al.	Immunoglobulin Heavy Chain Locus (IGH@) Translocations in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL): Incidence and Risk Stratification	2012
Dr Lisa Russell Professor Christine Harrison FRCPath FMedSci	Leukemia Cells with a BCR-ABL1-Like signature and/or IKZF1 deletions, but Not High CRLF2 Expression, Are Predictive of an Unfavorable Prognosis in Childhood B Cell Precursor Acute Lymphoblastic Leukemia	2012
Dr Lisa Russell Claire Schwab Professor Christine Harrison FRCPath FMedSci Professor Anthony Moorman	Outcome in children with Down's syndrome and acute lymphoblastic leukemia: role of IKZF1 deletions and CRLF2 aberrations	2012
Dr Lisa Russell	Small sizes and indolent evolutionary dynamics challenge the potential role of P2RY8-CRLF2-harboring clones as main relapse-driving force in childhood ALL	2012
Hannah Ensor Claire Schwab Dr Lisa Russell Professor Christine Harrison FRCPath FMedSci Professor Anthony Moorman et al.	Treatment outcome of CRLF2-rearranged childhood acute lymphoblastic leukaemia: a comparative analysis of the AIEOP-BFM and UK NCRI-CCLG study groups	2012
Hannah Ensor Claire Schwab Dr Lisa Russell Heather Morrison Dr Dino Masic et al.	Demographic, clinical, and outcome features of children with acute lymphoblastic leukemia and CRLF2 deregulation: results from the MRC ALL97 clinical trial	2011
Dr Vikki Rand Dr Lisa Russell Claire Schwab Hannah Ensor Professor Julie Irving et al.	Genomic characterization implicates iAMP21 as a likely primary genetic event in childhood B-cell precursor acute lymphoblastic leukemia	2011
Dr Lisa Russell Professor Christine Harrison FRCPath FMedSci	A new recurrent translocation t(11;14)(q24;q32) involving IGH@ and miR-125b-1 in B-cell progenitor acute lymphoblastic leukemia	2010
Dr Lisa Russell Professor Christine Harrison FRCPath FMedSci	Activating mutation in the TSLPR gene in B-cell precursor lymphoblastic leukemia	2010
Dr Lisa Russell Professor Christine Harrison FRCPath FMedSci	Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group	2010
Dr Lisa Russell Professor Olaf Heidenreich Professor Anthony Moorman Professor Christine Harrison FRCPath FMedSci	A novel translocation, t(14;19)(q32;p13) involving IGHalpha and the cytokine receptor for erythropoietin	2009
Dr Lisa Russell Professor Olaf Heidenreich Professor Julie Irving Professor Anthony Moorman Heather Morrison et al.	Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia	2009
Dr Vikki Rand Dr Lisa Russell Professor Julie Irving Lisa Jones Dr Dino Masic et al.	What Is the Initiating Mechanism of iAMP21 in Childhood B Cell Precursor ALL?	2009
Dr Lisa Russell Professor Christine Harrison FRCPath FMedSci	IDENTIFICATION OF MULTIPLE NOVEL IGH@ TRANSLOCATIONS IN ADOLESCENT ACUTE LYMPHOBLASTIC LEUKAEMIA.	2008
Dr Lisa Russell Professor Anthony Moorman Professor Olaf Heidenreich Professor Christine Harrison FRCPath FMedSci	IGH@ Translocations Involving the Pseudoautosomal Region 1 (PAR1) of Both Sex Chromosomes Deregulate the Cytokine Receptor-Like Factor 2 (CRLF2) Gene in B Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL)	2008
Dr Lisa Russell Professor Anthony Moorman Professor Christine Harrison FRCPath FMedSci	t(6;14)(p22;q32): a new recurrent IGH@ translocation involving ID4 in B-cell precursor acute lymphoblastic leukemia (BCP-ALL)	2008
Dr Lisa Russell Professor Christine Harrison FRCPath FMedSci	Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL)	2007
Dr Lisa Russell Professor Christine Harrison FRCPath FMedSci	Overexpression of CEBPA resulting from the translocation t(14;19)(q32;q13) of human precursor B acute lymphoblastic leukemia	2006